Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $1.18 Million - $1.47 Million
-23,312 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $54.4 Million - $62.7 Million
-908,495 Reduced 97.5%
23,312 $1.47 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $3.07 Million - $3.34 Million
-51,148 Reduced 5.2%
931,807 $57.1 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $54.3 Million - $62.7 Million
982,955
982,955 $62.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.